About This Show
ReachMD brings you the latest research, announcements, and conversations from the most important medical conferences around the world. Join us on the conference floor with keynote speakers, experts, and opinion leaders.
Most Recent Episode
Conference Coverage: Breaking News on Head and Neck Studies from the American Society for Radiation Oncology 58th Annual Meeting
Host: Jennifer Caudle, DO
Guest: Tanguy Seiwert, MD
The immunotherapeutic blockade of checkpoint inhibition that has resulted in stellar improvements in patient outcomes in melanoma and non-small cell lung cancer is now a likelihood for patients with head and neck cancer. Join us as Dr. Tanguy Seiwert discusses the mechanistic basis of checkpoint inhibition and the clinical data demonstrating the efficacy of anti-PD-1 agents in patients with head and neck cancer. Also discussed is the potential value of synergism between anti-checkpoint immunotherapy and current standards of care in head and neck cancer, as well as the growing relevance of biomarkers in identifying patients who will most benefit from immunotherapy.